Author

M. I. Breban

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Ecology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. B. F. Vogels· 2 shared C. B. Wilen· 2 shared N. D. Grubaugh· 2 shared A. Garbiel· 1 shared A. Iwasaki· 1 shared A. J. Porzucek· 1 shared A. M. Hahn· 1 shared A. M. Pyle· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersEcology

C. B. F. Vogels

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Survey of white-footed mice in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses

R. Earnest, A. M. Hahn, N. M. Feriancek, M. Brandt, R. B. Filler, Z. Zhao, M. I. Breban, C. B. F. Vogels, N. F. G. Chen, R. T. Koch, A. J. Porzucek, A. Sodeinde, A. Garbiel, C. Keanna, H. Litwak, , N. D. Grubaugh

The study surveys white-footed mice in Connecticut, finding low SARS-CoV-2 seroprevalence and identifying two divergent betacoronaviruses.

bioRxiv · Sep 22, 2023 · PreprintEcology

A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice

T. Mao, B. Israelow, C. Lucas, C. B. F. Vogels, O. Fedorova, M. I. Breban, B. L. Menasche, H. Dong, M. Linehan, Yale SARS-CoV-2 Genome Surveillance Initiative, C. B. Wilen, M. L. Landry, N. D. Grubaugh, A. M. Pyle, A. Iwasaki

This study shows that SLR14, a RIG-I agonist, prevents and treats SARS-CoV-2 infection in mice, including chronic cases and variants, through IFN-I responses.

bioRxiv · Jun 16, 2021Immunology